Quick Answer
HCA Healthcare, Inc. reported Diluted EPS of $28.33 per share for fiscal year 2025.
HCA Healthcare, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $28.33 | +28.8% |
| 2024 | $22.00 | +16.0% |
| 2023 | $18.97 | -0.9% |
| 2022 | $19.15 | -9.5% |
| 2021 | $21.16 | +93.6% |
| 2020 | $10.93 | +8.5% |
| 2019 | $10.07 | -5.5% |
| 2018 | $10.66 | +79.2% |
| 2017 | $5.95 | -18.5% |
| 2016 | $7.30 | +46.3% |
| 2015 | $4.99 | +20.0% |
| 2014 | $4.16 | +23.4% |
| 2013 | $3.37 | -3.4% |
| 2012 | $3.49 | -29.8% |
| 2011 | $4.97 | +80.1% |
| 2010 | $2.76 | +13.1% |
| 2009 | $2.44 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.96 | +42.6% | +1.9% |
| June 30, 2025 | $6.83 | +23.5% | +5.9% |
| March 31, 2025 | $6.45 | +8.8% | +32.2% |
| September 30, 2024 | $4.88 | +24.8% | -11.8% |
| June 30, 2024 | $5.53 | +28.9% | -6.7% |
| March 31, 2024 | $5.93 | +22.3% | +51.7% |
| September 30, 2023 | $3.91 | +0.0% | -8.9% |
| June 30, 2023 | $4.29 | +10.0% | -11.5% |
- HCA Healthcare, Inc. showed an increase of +28.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, HCA Healthcare, Inc.’s diluted eps has grown by 1061.1% (from $2.44 per share to $28.33 per share).
- The most recent figure is from HCA Healthcare, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: